Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Starpharma Holdings Ltd (OTCQX International:SPHRY)

5.23
Delayed Data
As of Dec 02
 +0.08 / +1.55%
Today’s Change
3.98
Today|||52-Week Range
5.95
-6.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-5.3M-13.4M-15.8M-16.5M
 
 
 
 
 
Depreciation1.1M1.0M1.0M677.5K
 
 
 
 
 
Total Other Cash Flow908.7K1.3M668.8K877.6K
 
 
 
 
 
Funds From Operations-3.4M-12.4M-14.1M-14.9M
 
 
 
 
 
Funds From/For Other Operating Expenses6.6M-2.1M-2.8M-2.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-10.0M-10.3M-11.3M-13.0M
 
 
 
 
 
 
InvestingDecrease In Investments0.000.000.0091.0K
 
 
Capital Expenditures-159.5K-230.4K-543.9K-70.6K
 
 
 
 
 
Fixed Asset Disposal0.00----727.69
 
 
Net Cash Flow Investing-159.5K-230.4K-543.9K21.1K
 
 
 
 
 
 
FinancingShort Term Borrowings--0.00------
Long Term Borrowings0.00--0.00----
Long Term Debt Reduction-51.1K-29.4K-26.7K-23.3K
 
 
 
 
 
Net Proceeds Stock Sale897.4K215.7K17.1M23.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing846.3K186.4K17.1M23.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash154.3K45.0K513.9K248.9K
 
 
 
 
 
 
Net Change In Cash-9.3M-10.4M5.2M10.8M